Bone marrow-sparing radiotherapy lowers pelvic marrow dose without proven toxicity reduction
Bone marrow-sparing planning reduced pelvic marrow dose, but heterogeneous evidence did not confirm a consistent reduction in hematologic toxicity.
Tag
The Radiation Oncology Feed
For radiation oncologists · physicists · RTTs · dosimetrists